22nd Century Group, Inc. (XXII)
$
0.74
Key metrics
Financial statements
Free cash flow per share
-8.8017
Market cap
5.6 Million
Price to sales ratio
0.2598
Debt to equity
1.5349
Current ratio
0.6767
Income quality
1.0261
Average inventory
2.3 Million
ROE
-5.4178
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
22nd Century Group, Inc., an agricultural biotechnology firm established in 1998 and based in Buffalo, New York, specializes in tobacco harm reduction, low nicotine tobacco products, and advancements in health and wellness through plant science. The company reported an income before tax of -$15,465,000.00 showcasing its pre-tax profitability. The gross profit ratio is -0.20 reflecting the efficiency of the company's production and sales operations. Additionally, the company recorded an operating income of -$13,950,000.00 which highlights its earnings from core operations while also incurring an interest expense of $2,094,000.00 reflecting its debt servicing obligations. The earnings per share (EPS) is reported at -$173.97 indicating the company's profitability on a per-share basis. To further its mission, 22nd Century Group develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes intended for use in independent clinical studies. Collaborating with Keygene N.V., the company is also focused on developing hemp and cannabis plants that exhibit exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, agricultural, and various applications. Currently, the stock is affordable at $0.74 making it suitable for budget-conscious investors. However, the stock has a low average trading volume of 767,312.00 indicating lower market activity. With a market capitalization of $5,635,905.00 the company is classified as a small-cap player, positioning itself as a key contributor in the Tobacco industry that significantly impacts the overall market landscape. Moreover, it belongs to the Consumer Defensive sector, driving innovation and growth within its domain. Through these strategic initiatives and market positioning, 22nd Century Group, Inc. continues to play a vital role in the advancement of agricultural biotechnology and tobacco harm reduction.
Is 22nd Century Group, Inc. (XXII) a good investment?
Investing in 22nd Century Group, Inc. (XXII) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bearish outlook. Always conduct your own research before investing.
What is 22nd Century Group, Inc. (XXII)'s stock forecast?
Analysts predict 22nd Century Group, Inc. stock to fluctuate between $0.70 (low) and $140.40 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is 22nd Century Group, Inc.'s market capitalization?
As of 2025-06-06, 22nd Century Group, Inc.'s market cap is $5,635,905, based on 7,605,810 outstanding shares.
How does 22nd Century Group, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., 22nd Century Group, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy 22nd Century Group, Inc. (XXII) stock?
To buy 22nd Century Group, Inc. (XXII) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for XXII. Place an order (Market, Limit, etc.).
What is the best time to invest in 22nd Century Group, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Has 22nd Century Group, Inc. stock ever split?
22nd Century Group, Inc.'s last stock split was 1:135 on 2024-12-17.
How did 22nd Century Group, Inc. perform in the last earnings report?
Revenue: $11,878,000 | EPS: -$173.97 | Growth: 49.37%.
Where can I find 22nd Century Group, Inc.'s investor relations reports?
Visit https://www.xxiicentury.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for 22nd Century Group, Inc.?
You can explore historical data from here
What is the all-time high and low for 22nd Century Group, Inc. stock?
All-time high: $196,668 (2021-04-26) | All-time low: $0.70 (2025-04-16).
What are the key trends affecting 22nd Century Group, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
globenewswire.com
MOCKSVILLE, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, (the “Company”) is pleased to announce that Larry Firestone, Chief Executive Officer, will present a brief corporate update at the Emerging Growth Conference on Wednesday, May 21, 2025, at 12:00 pm Eastern Time.
seekingalpha.com
22nd Century Group, Inc. (NASDAQ:XXII ) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ET Company Participants Matt Kreps - IR Larry Firestone - CEO Dan Otto - CFO Conference Call Participants Andrew White - Emerging Growth Research Operator Welcome to 22nd Century Group's First Quarter 2025 Conference Call and Webcast. At this time, all participants have been placed in a listen-only mode.
globenewswire.com
Sales Increase Approximately 50% Sequentially as 2025 Growth Strategy Drives New Sales Activity with Both Internal and External Brand Assets Across Multiple Categories
globenewswire.com
Further Strengthens Balance Sheet Cash Position MOCKSVILLE, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced closing of the sale of its Needle Rock Farms assets with net proceeds of approximately $770,000 after expenses.
globenewswire.com
MOCKSVILLE, N.C., April 17, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, (the “Company”) has released the following notice according to THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF NEW YORK:
globenewswire.com
MOCKSVILLE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, today announced execution of two new agreements from former customers to supply their filtered cigar products.
globenewswire.com
Launches 2025 Growth Strategy Leveraging Both Internal and External Brand Assets Across Multiple Categories Announces First VLN ® Partner Brands with Smoker Friendly Ready for Shipment in Q2 2025, Additional Partner VLN ® Brands in Discussion MOCKSVILLE, N.C., March 20, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced results for the fourth quarter and year-ended December 31, 2024, and provided an update on recent business highlights.
See all news
